Voulez-vous consulter la version mobile de ce site ?

Keynote speakers

Daniel Hayes

Daniel Hayes

Daniel F. Hayes, MD, FASCO, FACP Dr. Daniel F. Hayes is the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center, where he is the Stuart B. Padnos Professor of Breast Cancer Research. Dr. Hayes received bachelor’s, master’s and medical degrees from Indiana University, followed by a residency in internal medicine at the University of Texas Health Science Center/Parkland Memorial Hospital from 1979 to 1982. After a fellowship in medical oncology at Harvard’s Dana Farber Cancer Institute (DFCI) from 1982 to 1985, he remained on faculty and was the Medical Director of the Breast Evaluation Center at DFCI from 19912-1996. He subsequently became the Director of the Breast Cancer Program at Georgetown University’s Lombardi Cancer Center from 1996 to 2001, when he moved to the University of Michigan.

Y. M. Dennis Lo

Y. M. Dennis Lo

Dennis Lo is the Director of the Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong. He received his preclinical medical education from the University of Cambridge and his clinical training and postgraduate research training from the University of Oxford. He discovered the presence of cell-free fetal DNA in maternal plasma in 1997. Since then, he has been pushing forward the frontiers of the biology and diagnostic applications of circulating nucleic acids, in areas covering prenatal testing, oncology, and transplantation. In recognition of his work, Dennis Lo has been elected as a Fellow of the Royal Society and a Foreign Associate of the US National Academy of Sciences.

Joan Massagué

Joan Massagué

Joan Massagué, PhD: Director of Sloan Kettering Institute, Member of the Cancer Biology and Genetics Program. For 23 years Dr. Massagué served as Chairman of the Cancer Biology and Genetics Program and Cell Biology Program at Memorial Sloan Kettering Cancer Center. 1990-2013 he was appointed Investigator of the Howard Hughes Medical Institute and holds an Alfred P. Sloan Chair. He is a member of the National Academy of Sciences and Medicine and many other prestigious organizations. He received numerous awards for his research and recently the Pezcoller Foundation-AACR International Award for Cancer Research and Fellow, AACR Academy. Dr. Massagué is a world leader on investigating the mechanisms by which growth factors, signaling pathways and gene expression programs regulate normal cell proliferation as well as cancer metastasis. The research advances that he has produced are described in over 300 publications in scholarly scientific journals and ranks one of the most highly cited investigators in biomedical sciences.

Klaus Pantel

Klaus Pantel

Prof Pantel is Chairman of the Institute of Tumour Biology at the University Medical Center Hamburg- Eppendorf. The institute is part of the Centre of Experimental Medicine and the University Cancer Center Hamburg (UCCH). The pioneer work of Prof Pantel in the field of cancer micrometastasis, circulating tumor cells and circulating nucleic acids (ctDNA, microRNAs) is reflected by more than 400 publications in excellent high ranking biomedical and scientific journals (incl. NEJM, Lancet, Nature Journals, Cancer Cell, Science Translational Medicine, Cancer Discovery, PNAS, JCO, JNCI, Cancer Res.) and has been awarded the AACR Outstanding Investigator Award 2010, German Cancer Award 2010, and ERC Advanced Investigator Grant 2011. Moreover, Prof Pantel coordinates the European TRANSCAN group “CTC-SCAN”, the European IMI consortium CANCER-ID (www.cancer-id.eu) on blood-based “Liquid Biopsies” and serves on the Editorial Boards of international cancer journals (e.g., Breast Cancer Res., Cancer Res.).

Robert A. Weinberg

Robert A. Weinberg

An internationally recognized authority on the genetic basis of human cancer, Dr. Robert A. Weinberg is a founding member of the Whitehead Institute for Biomedical Research and the Daniel K. Ludwig Professor for Cancer Research at the Massachusetts Institute of Technology (MIT). He is also the first Director of the Ludwig Cancer Center at MIT. Over the past three decades, Dr. Weinberg has made breakthrough discoveries in the molecular and genetic roots of cancers. His lab discovered the first oncogene in 1982 and the first tumor suppressor gene in 1986. Most recently, Dr. Weinberg and his collogues were the first to define the genetic rules that must be followed in order for a normal human cell to be transformed into a human cancer cell. Dr. Weinberg’s lab is primarily concerned with how oncogenes, their normal counterparts (proto-oncogenes), and tumor suppressor genes fit together in the complex circuitry that controls cell growth. His lab recently succeeded in creating the first genetically defined human cancer cells. Dr. Weinberg is particularly interested in applying this knowledge to improve the diagnosis and treatment of breast cancer. At present his lab seeks to understand how a malicious population of tumor cells, called cancer stem cells, develop their metastatic powers and what biological conditions are required to eliminate them. Author or editor of six books and more than 400 articles, Dr. Weinberg is best known for his comprehensive cancer textbook, “The Biology of Cancer” 2nd edition. His other books, intended for a lay audience, are “One Renegade Cell”, "Racing to the Beginning of the Road: The Search for the Origin of Cancer" and "Genes and the Biology of Cancer," co-authored with Dr. Harold E. Varmus, former Director of the National Institutes of Health. Dr. Weinberg is an elected Member of the U.S. National Academy of Sciences and Fellow of the American Academy of Arts and Sciences. He is also a Member of the American Philosophical Society and the Institute of Medicine. He has received the National Medal of Science (1997), the Wolf Prize in Medicine (2007), the Otto Warburg Medal (2007), and the Breakthrough Prize in Life Sciences (2013)

Congress date : May 3-5 2018

Organizing committee

Catherine Alix-Panabières
Klaus Pantel

Download Programme

Programme

Important
Dates

  • 15th December 2017
    End of the early registration fees
  • 1st February 2018
    Abstract submission deadline
  • 15th March 2018
    Notification of abstract acceptance & Travel awards
  • 15th April 2018
    End of the standard registration fees
  • 3rd May 2018
    Opening of the ISMRC 2018

Photo
gallery

Montpellier Go to the gallery